Caribou Biosciences Inc. (NASDAQ: CRBU) on January 24, 2023, started off the session at the price of $6.44, soaring 4.34% from the previous trading day. During the day, the shares moved up to $6.81 and dropped to $6.37 before settling in for the closing price of $6.45. Within the past 52 weeks, CRBU’s price has moved between $4.89 and $13.19.
The company achieved an average annual earnings per share of -83.60%. With a float of $54.41 million, this company’s outstanding shares have now reached $60.89 million.
The firm has a total of 97 workers. Let’s measure their productivity. In terms of profitability, gross margin is +89.75, operating margin of -697.84, and the pretax margin is -693.92.
Caribou Biosciences Inc. (CRBU) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Caribou Biosciences Inc. is 1.30%, while institutional ownership is 72.10%. The most recent insider transaction that took place on Jan 19, was worth 35,506. In this transaction Chief Medical Officer of this company sold 5,627 shares at a rate of $6.31, taking the stock ownership to the 59,373 shares. Before that another transaction happened on Oct 06, when Company’s VP of Finance and Controller sold 10,000 for $10.80, making the entire transaction worth $107,958. This insider now owns 110,366 shares in total.
Caribou Biosciences Inc. (CRBU) Earnings and Forecasts
As on 6/29/2022, Multinational firm has announced its last quarter scores, in which it reported -$0.44 earnings per share (EPS) for the period falling under the consensus outlook (set at -$0.36) by -$0.08. This company achieved a net margin of -697.26 while generating a return on equity of -36.73. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.5 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -83.60% per share during the next fiscal year.
Caribou Biosciences Inc. (NASDAQ: CRBU) Trading Performance Indicators
Caribou Biosciences Inc. (CRBU) is currently performing well based on its current performance indicators. A quick ratio of 10.70 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 31.82.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.50, a number that is poised to hit -0.46 in the next quarter and is forecasted to reach -1.96 in one year’s time.
Technical Analysis of Caribou Biosciences Inc. (CRBU)
Analysing the last 5-days average volume posted by the [Caribou Biosciences Inc., CRBU], we can find that recorded value of 0.51 million was better than the volume posted last year of 0.5 million. As of the previous 9 days, the stock’s Stochastic %D was 23.78%. Additionally, its Average True Range was 0.47.
During the past 100 days, Caribou Biosciences Inc.’s (CRBU) raw stochastic average was set at 17.07%, which indicates a significant decrease from 38.98% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 71.99% in the past 14 days, which was higher than the 70.77% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.86, while its 200-day Moving Average is $8.48. Now, the first resistance to watch is $6.90. This is followed by the second major resistance level at $7.08. The third major resistance level sits at $7.34. If the price goes on to break the first support level at $6.46, it is likely to go to the next support level at $6.20. Should the price break the second support level, the third support level stands at $6.02.
Caribou Biosciences Inc. (NASDAQ: CRBU) Key Stats
Market capitalization of the company is 404.14 million based on 61,002K outstanding shares. Right now, sales total 9,600 K and income totals -66,920 K. The company made 3,300 K in profit during its latest quarter, and -26,650 K in sales during its previous quarter.